CLIMB BIO INC. - COMMON STOCK
3.0500
22-نوفمبر-24 16:44:58
15 متأخرة بدقائق
الأسهم
+0.0500
+1.67%
نطاق اليوم
3.0150 - 3.3000
ISIN
N/A
المصدر
NASDAQ
-
Eliem Therapeutics to Participate at Two Upcoming Investor Conferences
08 نوفمبر 2022 07:00:02 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Provides Update on Pipeline Progress
05 أكتوبر 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Second Quarter Financial and Business Highlights
15 أغسطس 2022 06:10:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Provides ETX-810 Program Update
02 أغسطس 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
18 يوليو 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics to Host Virtual Investor Event on July 21, 2022
07 يوليو 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
27 يونيو 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports First Quarter Financial and Business Highlights
16 مايو 2022 06:10:00 بحسب Nasdaq GlobeNewswire
-
Eliem Provides Update on ETX-810 and ETX-155 Clinical Programs
25 أبريل 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Appoints Susan Franks as Senior Vice President and Head of Regulatory Affairs
05 أبريل 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics to Present at Stifel’s 2022 CNS Days
21 مارس 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial and Business Highlights
07 مارس 2022 16:10:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
11 فبراير 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
07 فبراير 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Provides Program Updates and an Overview of Expected Near-Term Milestones
18 يناير 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
08 نوفمبر 2021 16:01:00 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics to Participate at Four Upcoming Investor Conferences
04 نوفمبر 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Second Quarter Financial Results
13 سبتمبر 2021 16:10:00 بحسب Nasdaq GlobeNewswire
-
12 أغسطس 2021 21:06:11 بحسب Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces Pricing of Initial Public Offering
09 أغسطس 2021 22:33:09 بحسب Nasdaq GlobeNewswire